Nutex health reports first quarter 2025 financial results
Total revenue of $211.8 million versus $67.5 million in q1 2024, an increase of 213.8% net income attributable to nutex health inc. of $14.6 million versus net loss of $0.4 million in q1 2024 diluted eps of $2.56 per share versus $(0.08) per share in q1 2024 ebitda of $43.1 million versus $7.1 million in ebitda in q1 2024, an increase of 507.0% adjusted ebitda of $72.8 million versus $(0.4) million in q1 2024 net cash from operating activities of $51.0 million company believes its arbitration efforts through the independent dispute resolution (idr) process have resulted in more fair and reasonable payments houston , may 13, 2025 /prnewswire/ -- nutex health inc. ("nutex health" or the "company") (nasdaq: nutx), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (hopds) in 11 states and primary care-centric, risk-bearing physician networks, today announced first quarter 2025 financial results for the three months ended march 31, 2025.
NUTX Ratings Summary
NUTX Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission